Basilar artery occlusion with large brain infarct: real-world endovascular vs medical therapy
Official title: Endovascular Versus Medical Therapy for Acute Large-Core Basilar Artery Occlusion: A Multicenter Retrospective Registry Study (BAOCHE-LC)
Run by Xuanwu Hospital, Beijing · NCT07345702 · Data updated 2026-11-12
This registry follows adults with basilar artery occlusion and a large core infarct to see how endovascular therapy compares to medical management in routine care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 518 (estimated) |
| Sponsor | Xuanwu Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | January 31, 2026 |
| Main results expected | October 31, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | July 30, 2026 |
| Trial ID | NCT07345702 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with basilar artery or intracranial vertebral artery occlusions and a large posterior circulation infarct (pc-ASPECTS 0-5) treated within 7 days.
✕Probably not a fit
Patients with occlusions outside the studied posterior circulation or those with small infarcts or missing key data may have limited applicability.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter retrospective registry collects data from patients treated in typical clinical practice. It compares safety and effectiveness of endovascular therapy against medical therapy for acute large-core basilar artery occlusion. The study analyzes clinical, imaging, and laboratory factors to identify associations with functional outcomes and mortality. Patients are grouped by the treatment they actually received in real-world settings. The setting is a Beijing-based hospital with multiple centers contributing data.
Why it matters
Potential benefit: If successful, the registry could clarify real-world outcomes for endovascular therapy in this high-risk group and guide treatment decisions.
How similar studies have gone: Previous work in similar stroke populations has shown mixed results, and this observational registry aims to build real-world evidence rather than a controlled trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years, men or women. 2. Occlusion (TIMI 0-1) of the basilar artery or intracranial segments of both vertebral arteries (V4) as evidenced by CTA/MRA/DSA. 3. Time from symptom onset (or last known well) to treatment (endovascular therapy or medical therapy) ≤7 days. 4. Patients with large core infarction in the posterior circulation, defined as a posterior circulation Acute Stroke Prognosis Early CT score (pc-ASPECTS) score of 0-5 on CT angiography source images or MR with diffusion-weighted imaging or non-contrast CT. Exclusion Criteria: 1. Subjects with occlusions in both anterior and posterior circulation. 2. CT or MR evidence of hemorrhage (the presence of microbleeds on MRI is allowed). 3. Missing key clinical information (e.g., unavailable baseline NIHSS, unclear symptom onset/last known well time, or missing major treatment information including whether EVT was performed). 4. Baseline NIHSS score \<6. 5. Woman of childbearing potential who is known to be pregnant or lactating or who has a positive pregnancy test on admission. 6. Missing follow-up outcomes at 90 days. 7. Any other condition judged by investigators to substantially affect analysis or interpretation.
Where it's running
-
Xuanwu Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Chuanhui Li
- Email: lichuanhui@xwh.ccmu.edu.cn
- Phone: 15210439828
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endovascular treatment for acute basilar artery stroke with a large infarct core
This trial will test whether adding endovascular clot removal to standard medical care helps adults with acute basilar artery occlusion who already have a large area of brain damage.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)
This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.